According to the World’s Best Specialized Hospitals 2021 ranking by Newsweek magazine, Gustave Roussy is in 5th position worldwide and 1st hospital outside of the United States. This ranking emphasizes the international recognition for excellence in care and powerful research performed by the Institute. It also means that patients, whose decision to choose the right hospital is determined mainly by the hospital’s reputation, can be confident and receive in France both the best care and the most effective clinical research.
"We are proud to be one of the world's top 5 cancer centers along with four American giants. This ranking is an important recognition of our savoir-faire and team expertise. Both our medical staff and scientists play an important part in making French healthcare one of the best in the world. Gustave Roussy has the ability to meet all the challenges of the 21st century: to detect, to study, to fight against, to care for and to overcome cancer" explains Professor Jean-Charles Soria, CEO of Gustave Roussy.
This new ranking reinforces Gustave Roussy's international reputation. Honored every year in the Clarivate ranking, with 10 of its experts featuring in the 2019 list of the world's most "Highly cited researchers". Gustave Roussy's physician-scientists are also regularly awarded prizes at international congresses by learned societies or major research organizations or foundations. Knowledge production is intensive, with 1,800 international publications, including more than 60 in highly cited papers (journal impact factor greater than 30).
Today, the Institute is a key player in the world for early trials, immunotherapy and precision medicine clinical trials. Nearly a quarter of Gustave Roussy's patients are part of a clinical study.
Today, by developing its new institutional strategic plan for the next ten years, Gustave Roussy is all geared up for the fight against cancer and the growing complexity of the disease, all for the benefit of their patients.